Abstract:Background: Cefteram pivoxil (CFTM-PI) is an oral antibiotic available in powder suspension and tablet formulations indicated in China for the treatment of bacterial infections. Although these 2 formulations are marketed in China, published information regarding their pharmacokinetics and bioequivalence in the Chinese population is not available.Objective: The aim of this study was to compare the pharmacokinetics and bioequivalence of the powder suspension (test) and tablet (reference) formulations of CFTM-PI 100 mg available in China.Methods: This single-dose, randomized-sequence, open-label, 2-period crossover study was performed at the Nanjing First Hospital of Nanjing Medical University. Eligible subjects were healthy male volunteers who were randomly assigned at a 1:1 ratio to receive a single 100-mg dose of the test or reference formulation, followed by a 1-week washout period and administration of the alternate formulation. The study drugs were administered after a 12-hour overnight fast. Plasma was assayed using a high-performance liquid chromatography method. For analysis of pharmacokinetic properties, including C-max, AUC from time 0 (baseline) to 6 hours (AUC(0-6)), and AUC from baseline to infinity (AUC(0-infinity)), blood samples were obtained at intervals over the 6-hour period after study drug administration. The formulations were considered bioequivalent if the log-transformed ratios of C-max and AUC were within the predetermined equivalence range (80%-125%) as established by the US Food and Drug Administration (FDA). Tolerability was assessed by monitoring vital signs and laboratory tests (hematology, blood biochemistry, hepatic function, and urinalysis), and by questioning subjects about adverse events (AEs).Results: Twenty-four Chinese male subjects (mean [range] age, 24.2 [23-32] years; weight, 64.3 [58-67] kg; height, 172 [167-185] cm) enrolled; all completed the study. No period or sequence effect was observed. The 90% Cls for the log-transformed ratios of C-max, AUC(0-6) and AUC(0-infinity) were 96.5 to 120.1, 95.7 to 110.2, and 96.2 to 110.4, respectively (all, P > 0.05). Similar results were found for the data without log-transformation. No AEs occurred or were reported during the study.Conclusions: In this small study in healthy Chinese adult male volunteers, a single 100-mg dose of the powder-suspension formulation was bioequivalent to a single 100-mg dose of the tablet formulation based on the US FDA's regulatory definition (rate and extent of absorption). Both formulations were well tolerated.

Bioequivalence Evaluation of 2 Tablet Formulations of Entecavir in Healthy Chinese Volunteers: A Single-Dose, Randomized-Sequence, Open-Label Crossover Study

Bioequivalence evaluation of 2 tablet formulations of entecavir in healthy chinese volunteers: a single-dose, randomized-sequence, open-label crossover study.

Bioequivalence of 2 Kinds of Entecavir Preparations in Healthy Volunteers

Studies on Bioequivalence of Indinavir Capsule in Healthy Volunteers

Study on bioequivalence of cilostazol table in healthy volunteers

Bioequivalence of Two Formulations of a Single Oral Dose of 500-Mg Azithromycin Granules: A Randomized, Open-Label, Two-Period Crossover Study in Healthy Han Chinese Volunteers.

Simple and Rapid UPLC-MS/MS Method for Quantification of Entecavir in Human Plasma: Application to a Bioequivalence Study

Bioequivalence Study of Two Esomeprazole Enteric Coated Formulations in Healthy Chinese Volunteers

Pharmacokinetics of entecavir maleate tablets in healthy Chinese volunteers

Bioequivalence Evaluation of Two Rabeprazole Enteric Coated Formulations in Healthy Chinese Volunteers

Bioequivalence of Clarithromycin Soft Capsules in Healthy Chinese Volunteers

Bioequivalence Study of Voriconazole Tablet in Healthy Chinese Male Volunteers

Pharmacokinetic and Bioequivalence Comparison of a Single 100-Mg Dose of Cefteram Pivoxil Powder Suspension and Tablet Formulations: a Randomized-Sequence, Open-Label, Two-Period Crossover Study in Healthy Chinese Adult Male Volunteers

Pharmacokinetics and Bioequivalence Study of Valacyclovir Hydrochloride Capsules after Single Dose Administration in Healthy Chinese Male Volunteers

Bioequivalence of Clarithromycin Dispersed Tablet in Health Volunteers

Pharmacokinetic and Bioequivalence Evaluation of Single-Tablet and Separate-Tablet Regimens for Ainuovirine, Lamivudine, and Tenofovir Disoproxil Fumarate in Chinese Healthy Subjects

Bioequivalence and Pharmacokinetics Study of Two Zidovudine/Lamivudine Tablets in Chinese Healthy Volunteers

Bioequivalence of Two Domestic Praperations of Metformin Hydrochloride Entericcoated Capsules in Chinese Healthy Volunteers

Pharmacokinetic and bioequivalence studies of trospium chloride after a single-dose administration in healthy Chinese volunteers.

Pharmacokinetics and bioequivalence study of escitalopram oxalate formulations after single-dose administration in healthy Chinese male volunteers

Bioequivalence of Lisinopril Tablets in Health Volunteers